Quick Reliever Medicines for Asthma and COPD - Global Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Pharma & Healthcare > Quick Reliever Medicines for Asthma and COPD - Global Top Players Market Share and Ranking 2025

Quick Reliever Medicines for Asthma and COPD - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-09-14
Report Id: 2377161
Industry: Pharma & Healthcare
Report Page: 119
Chart: 112

PDF Download

Publication Date: 2025-09-14
Report Id: 2377161
Industry: Pharma & Healthcare
Report Page: 119
Chart: 112

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Quick Reliever Medicines for Asthma and COPD Definition
1.2 Global Quick Reliever Medicines for Asthma and COPD Market Size and Forecast
1.2.1 By Consumption Value, Global Quick Reliever Medicines for Asthma and COPD Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Quick Reliever Medicines for Asthma and COPD Market Size, 2020-2031
1.2.3 Global Quick Reliever Medicines for Asthma and COPD Average Selling Price (ASP), 2020-2031
1.3 China Quick Reliever Medicines for Asthma and COPD Market Size and Forecast
1.3.1 By Consumption Value, China Quick Reliever Medicines for Asthma and COPD Market Size, 2020-2031
1.3.2 By Sales Quantity, China Quick Reliever Medicines for Asthma and COPD Market Size, 2020-2031
1.3.3 China Quick Reliever Medicines for Asthma and COPD Average Selling Price (ASP), 2020-2031
1.4 Share of China Quick Reliever Medicines for Asthma and COPD Market with Respect to the Global Market
1.4.1 By Consumption Value, China Quick Reliever Medicines for Asthma and COPD Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Quick Reliever Medicines for Asthma and COPD Market Share in Global, 2020-2031
1.4.3 Quick Reliever Medicines for Asthma and COPD Market Size: China VS Global, 2020-2031
1.5 Quick Reliever Medicines for Asthma and COPD Market Dynamics
1.5.1 Quick Reliever Medicines for Asthma and COPD Market Drivers
1.5.2 Quick Reliever Medicines for Asthma and COPD Market Restraints
1.5.3 Quick Reliever Medicines for Asthma and COPD Industry Trends
1.5.4 Quick Reliever Medicines for Asthma and COPD Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Quick Reliever Medicines for Asthma and COPD, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Quick Reliever Medicines for Asthma and COPD, Global Market Share by Company, 2020-2025
2.3 Quick Reliever Medicines for Asthma and COPD Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Quick Reliever Medicines for Asthma and COPD Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Quick Reliever Medicines for Asthma and COPD Concentration Ratio
2.6 Global Quick Reliever Medicines for Asthma and COPD Mergers & Acquisitions, Expansion Plans
2.7 Global Quick Reliever Medicines for Asthma and COPD Manufacturers Product Type
2.8 Head Office and Quick Reliever Medicines for Asthma and COPD Production Site of Key Manufacturer
2.9 Quick Reliever Medicines for Asthma and COPD Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Quick Reliever Medicines for Asthma and COPD, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Quick Reliever Medicines for Asthma and COPD, China Market Share by Company, 2020-2025
3.3 China Quick Reliever Medicines for Asthma and COPD Quick Reliever Medicines for Asthma and COPD Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Quick Reliever Medicines for Asthma and COPD Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Quick Reliever Medicines for Asthma and COPD Capacity by Region
4.3 Global Quick Reliever Medicines for Asthma and COPD Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Quick Reliever Medicines for Asthma and COPD Production by Region, 2020-2031
4.5 Global Quick Reliever Medicines for Asthma and COPD Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Quick Reliever Medicines for Asthma and COPD Industry Chain
5.2 Quick Reliever Medicines for Asthma and COPD Upstream Analysis
5.2.1 Quick Reliever Medicines for Asthma and COPD Core Raw Materials
5.2.2 Main Manufacturers of Quick Reliever Medicines for Asthma and COPD Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Quick Reliever Medicines for Asthma and COPD Production Mode
5.6 Quick Reliever Medicines for Asthma and COPD Procurement Model
5.7 Quick Reliever Medicines for Asthma and COPD Industry Sales Model and Sales Channels
5.7.1 Quick Reliever Medicines for Asthma and COPD Sales Model
5.7.2 Quick Reliever Medicines for Asthma and COPD Typical Distributors

6 Sights by Type
6.1 Quick Reliever Medicines for Asthma and COPD Classification by Type
6.1.1 Short-Acting Beta2-Agonists (SABA)
6.1.2 Short-Acting Muscarinic Antagonists (SAMA)
6.1.3 SABA-ICS
6.1.4 SABA-SAMA
6.2 by Type, Global Quick Reliever Medicines for Asthma and COPD Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Quick Reliever Medicines for Asthma and COPD Consumption Value, 2020-2031
6.4 by Type, Global Quick Reliever Medicines for Asthma and COPD Sales Quantity, 2020-2031
6.5 by Type, Global Quick Reliever Medicines for Asthma and COPD Average Selling Price (ASP), 2020-2031

7 Sights by Application
7.1 Quick Reliever Medicines for Asthma and COPD Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Others
7.2 by Application, Global Quick Reliever Medicines for Asthma and COPD Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Quick Reliever Medicines for Asthma and COPD Consumption Value, 2020-2031
7.4 by Application, Global Quick Reliever Medicines for Asthma and COPD Sales Quantity, 2020-2031
7.5 by Application, Global Quick Reliever Medicines for Asthma and COPD Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Quick Reliever Medicines for Asthma and COPD Consumption Value, 2020 VS 2024 VS 2031
8.2 By Region, Global Quick Reliever Medicines for Asthma and COPD Consumption Value, 2020-2031
8.3 By Region, Global Quick Reliever Medicines for Asthma and COPD Sales Quantity, 2020-2031
8.4 North America
8.4.1 North America Quick Reliever Medicines for Asthma and COPD Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Quick Reliever Medicines for Asthma and COPD Market Size Market Share
8.5 Europe
8.5.1 Europe Quick Reliever Medicines for Asthma and COPD Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Quick Reliever Medicines for Asthma and COPD Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Quick Reliever Medicines for Asthma and COPD Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Quick Reliever Medicines for Asthma and COPD Market Size Market Share
8.7 South America
8.7.1 South America Quick Reliever Medicines for Asthma and COPD Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Quick Reliever Medicines for Asthma and COPD Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Quick Reliever Medicines for Asthma and COPD Market Size & CAGR, 2020 VS 2024 VS 2031
9.2 By Country, Global Quick Reliever Medicines for Asthma and COPD Consumption Value, 2020-2031
9.3 By Country, Global Quick Reliever Medicines for Asthma and COPD Sales Quantity, 2020-2031
9.4 United States
9.4.1 United States Quick Reliever Medicines for Asthma and COPD Market Size, 2020-2031
9.4.2 by Type, United States Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.4.3 by Application, United States Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Quick Reliever Medicines for Asthma and COPD Market Size, 2020-2031
9.5.2 by Type, Europe Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.5.3 by Application, Europe Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.6 China
9.6.1 China Quick Reliever Medicines for Asthma and COPD Market Size, 2020-2031
9.6.2 by Type, China Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.6.3 by Application, China Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Quick Reliever Medicines for Asthma and COPD Market Size, 2020-2031
9.7.2 by Type, Japan Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.7.3 by Application, Japan Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Quick Reliever Medicines for Asthma and COPD Market Size, 2020-2031
9.8.2 by Type, South Korea Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.8.3 by Application, South Korea Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Quick Reliever Medicines for Asthma and COPD Market Size, 2020-2031
9.9.2 by Type, Southeast Asia Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.9.3 by Application, Southeast Asia Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.10 India
9.10.1 India Quick Reliever Medicines for Asthma and COPD Market Size, 2020-2031
9.10.2 by Type, India Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.10.3 by Application, India Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Quick Reliever Medicines for Asthma and COPD Market Size, 2020-2031
9.11.2 by Type, Middle East & Africa Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031
9.11.3 by Application, Middle East & Africa Quick Reliever Medicines for Asthma and COPD Sales Quantity Market Share, 2024 VS 2031

10 Manufacturers Profile
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
10.1.2 Boehringer Ingelheim Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.1.3 Boehringer Ingelheim Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Boehringer Ingelheim Company Profile and Main Business
10.1.5 Boehringer Ingelheim Recent Developments
10.2 GSK
10.2.1 GSK Company Information, Head Office, Market Area, and Industry Position
10.2.2 GSK Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.2.3 GSK Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.2.4 GSK Company Profile and Main Business
10.2.5 GSK Recent Developments
10.3 Teva Pharmaceutical
10.3.1 Teva Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.3.2 Teva Pharmaceutical Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.3.3 Teva Pharmaceutical Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Teva Pharmaceutical Company Profile and Main Business
10.3.5 Teva Pharmaceutical Recent Developments
10.4 Prasco Laboratories
10.4.1 Prasco Laboratories Company Information, Head Office, Market Area, and Industry Position
10.4.2 Prasco Laboratories Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.4.3 Prasco Laboratories Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Prasco Laboratories Company Profile and Main Business
10.4.5 Prasco Laboratories Recent Developments
10.5 Cipla
10.5.1 Cipla Company Information, Head Office, Market Area, and Industry Position
10.5.2 Cipla Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.5.3 Cipla Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.5.4 Cipla Company Profile and Main Business
10.5.5 Cipla Recent Developments
10.6 Lupin Laboratories
10.6.1 Lupin Laboratories Company Information, Head Office, Market Area, and Industry Position
10.6.2 Lupin Laboratories Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.6.3 Lupin Laboratories Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Lupin Laboratories Company Profile and Main Business
10.6.5 Lupin Laboratories Recent Developments
10.7 Laboratorio Aldo-Union
10.7.1 Laboratorio Aldo-Union Company Information, Head Office, Market Area, and Industry Position
10.7.2 Laboratorio Aldo-Union Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.7.3 Laboratorio Aldo-Union Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.7.4 Laboratorio Aldo-Union Company Profile and Main Business
10.7.5 Laboratorio Aldo-Union Recent Developments
10.8 Polpharma
10.8.1 Polpharma Company Information, Head Office, Market Area, and Industry Position
10.8.2 Polpharma Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.8.3 Polpharma Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.8.4 Polpharma Company Profile and Main Business
10.8.5 Polpharma Recent Developments
10.9 Jewim Pharmaceutical
10.9.1 Jewim Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.9.2 Jewim Pharmaceutical Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.9.3 Jewim Pharmaceutical Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Jewim Pharmaceutical Company Profile and Main Business
10.9.5 Jewim Pharmaceutical Recent Developments
10.10 Heilongjiang Fulekang Pharmaceutical
10.10.1 Heilongjiang Fulekang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.10.2 Heilongjiang Fulekang Pharmaceutical Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.10.3 Heilongjiang Fulekang Pharmaceutical Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.10.4 Heilongjiang Fulekang Pharmaceutical Company Profile and Main Business
10.10.5 Heilongjiang Fulekang Pharmaceutical Recent Developments
10.11 Shanghai Pharmaceuticals
10.11.1 Shanghai Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.11.2 Shanghai Pharmaceuticals Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.11.3 Shanghai Pharmaceuticals Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.11.4 Shanghai Pharmaceuticals Company Profile and Main Business
10.11.5 Shanghai Pharmaceuticals Recent Developments
10.12 Lunan Better Pharmaceutical
10.12.1 Lunan Better Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.12.2 Lunan Better Pharmaceutical Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.12.3 Lunan Better Pharmaceutical Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.12.4 Lunan Better Pharmaceutical Company Profile and Main Business
10.12.5 Lunan Better Pharmaceutical Recent Developments
10.13 China Resources Double Crane Pharmaceutical
10.13.1 China Resources Double Crane Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.13.2 China Resources Double Crane Pharmaceutical Quick Reliever Medicines for Asthma and COPD Models, Specifications, and Application
10.13.3 China Resources Double Crane Pharmaceutical Quick Reliever Medicines for Asthma and COPD Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.13.4 China Resources Double Crane Pharmaceutical Company Profile and Main Business
10.13.5 China Resources Double Crane Pharmaceutical Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Quick Reliever Medicines for Asthma and COPD should grow from US$ 5173 million in 2024 to US$ 6715 million by 2031, with a CAGR of 3.9% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Quick Reliever Medicines for Asthma and COPD

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Quick reliever medicines for asthma and COPD primarily consist of short-acting β2-agonists (such as salbutamol) and anticholinergic agents, with upstream supply chains including active pharmaceutical ingredients (APIs), excipients, and propellants for inhalation formulations. The upstream is dominated by large international API manufacturers and specialized excipient suppliers, while production is led by multinational pharmaceutical companies and regional manufacturers. Downstream customers mainly include hospitals, retail pharmacies, and long-term patients with chronic respiratory diseases. As these medicines are essential for acute symptom relief, market demand remains stable and rigid.

In 2024, the global average price of quick reliever medicines for asthma and COPD is approximately USD 20.3 per unit, with total sales reaching around 239 million units.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Quick Reliever Medicines for Asthma and COPD market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031. The United States Quick Reliever Medicines for Asthma and COPD market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.

This report studies and analyses global Quick Reliever Medicines for Asthma and COPD status and future trends, helps the client to determine the Quick Reliever Medicines for Asthma and COPD market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Quick Reliever Medicines for Asthma and COPD, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Quick Reliever Medicines for Asthma and COPD market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Quick Reliever Medicines for Asthma and COPD sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Quick Reliever Medicines for Asthma and COPD sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Quick Reliever Medicines for Asthma and COPD key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Quick Reliever Medicines for Asthma and COPD key producing regions, capacity, production, and year over year growth
(6) Quick Reliever Medicines for Asthma and COPD industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Boehringer Ingelheim
GSK
Teva Pharmaceutical
Prasco Laboratories
Cipla
Lupin Laboratories
Laboratorio Aldo-Union
Polpharma
Jewim Pharmaceutical
Heilongjiang Fulekang Pharmaceutical
Shanghai Pharmaceuticals
Lunan Better Pharmaceutical
China Resources Double Crane Pharmaceutical

Market segment by Type, covers
Short-Acting Beta2-Agonists (SABA)
Short-Acting Muscarinic Antagonists (SAMA)
SABA-ICS
SABA-SAMA

Market segment by Application, can be divided into
Hospital
Clinic
Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Quick Reliever Medicines for Asthma and COPD product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Quick Reliever Medicines for Asthma and COPD market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Quick Reliever Medicines for Asthma and COPD market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Quick Reliever Medicines for Asthma and COPD, percent & CAGR, 2020-2031
Chapter 5: Quick Reliever Medicines for Asthma and COPD industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.